이식형 인슐린 펌프 시장 규모, 점유율, 성장 분석 : 펌프 유형별, 레저버 용량별, 투여 모드별, 최종사용자별, 연령층별, 적응증별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Implantable Insulin Pump Market size was valued at USD 39.35 Billion in 2024 and is poised to grow from USD 48.08 Billion in 2025 to USD 239.09 Billion by 2033, growing at a CAGR of 22.2% during the forecast period (2026-2033).

The global implantable insulin pump market is experiencing significant growth fueled by the increasing prevalence of diabetes and a rising demand for sophisticated insulin delivery systems. Patients are opting for continuous and precise insulin management, driven by a desire to minimize blood sugar fluctuations and long-term complications. Technological advancements have led to more reliable, user-friendly pump designs, while heightened awareness of effective diabetes management strategies supports market expansion. Additionally, favorable healthcare policies and reimbursement programs are making these devices more accessible. However, challenges such as high costs associated with the pumps and surgical procedures, limited awareness in developing regions, rigorous regulatory requirements, potential infection risks, and ongoing maintenance needs may hinder market growth in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Implantable Insulin Pump market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Implantable Insulin Pump Market Segments Analysis

Global Implantable Insulin Pump Market is segmented by Pump Type, Reservoir Size, Delivery Mode, End User, Age Group, Indication, Distribution Channel and region. Based on Pump Type, the market is segmented into Programmable Implantable Pumps, Closed-loop Pumps, Open-loop Pumps, Non-programmable Implantable Pumps and Others. Based on Reservoir Size, the market is segmented into Small Volume (<=10 mL), Medium Volume (10-20 mL), Large Volume (>20 mL) and Others. Based on Delivery Mode, the market is segmented into Continuous Basal Delivery, Bolus Delivery, Combined Basal-Bolus Delivery and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Diabetes Clinics, Homecare Settings and Others. Based on Age Group, the market is segmented into Pediatric (<=17 years), Adults (18-64 years) and Geriatric (>=65 years). Based on Indication, the market is segmented into Type 1 Diabetes Mellitus (T1DM), Type 2 Diabetes Mellitus (T2DM) and Others. Based on Distribution Channel, the market is segmented into Pediatric (<=17 years), Adults (18-64 years) and Geriatric (>=65 years). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Implantable Insulin Pump Market

One of the key market drivers for the global implantable insulin pump market is the rising prevalence of diabetes worldwide, particularly type 1 diabetes. As awareness of diabetes management and the importance of maintaining optimal blood glucose levels increases, there is a growing demand for advanced diabetes care solutions, such as implantable insulin pumps. These devices not only enhance patient convenience by providing continuous insulin delivery but also improve glycemic control, thereby reducing the risk of complications associated with diabetes. Additionally, technological advancements and innovations in pump designs are further propelling the adoption of these devices among patients seeking effective management options.

Restraints in the Global Implantable Insulin Pump Market

One significant market restraint for the global implantable insulin pump market is the high cost associated with these advanced medical devices. The initial purchase price, coupled with ongoing expenses for maintenance, supplies, and healthcare consultations, can be prohibitive for many patients, particularly in developing regions where healthcare funding is limited. Additionally, the reimbursement landscape is often inconsistent, leading to financial barriers for patients seeking access to these innovative technologies. This economic challenge may deter adoption rates and limit the growth potential of the implantable insulin pump market, impacting both manufacturers and end-users seeking effective diabetes management solutions.

Market Trends of the Global Implantable Insulin Pump Market

The global implantable insulin pump market is experiencing a significant trend towards the integration of advanced technologies, particularly continuous glucose monitoring (CGM) systems. This synergy is leading to the development of closed-loop systems, often considered artificial pancreas solutions, which enable automatic insulin delivery adjustments based on real-time glucose readings. Such innovations are not only enhancing treatment precision but also simplifying daily management for users, reducing the need for constant monitoring and manual input. Consequently, the market is witnessing a growing demand for these smart implantable devices, which boost patient confidence and improve overall diabetes management outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Implantable Insulin Pump Market Size by Pump Type & CAGR (2026-2033)

• Market Overview
• Programmable Implantable Pumps
• Closed-loop Pumps
• Open-loop Pumps
• Non-programmable Implantable Pumps
• Others

Global Implantable Insulin Pump Market Size by Reservoir Size & CAGR (2026-2033)

• Market Overview
• Small Volume (<=10 mL)
• Medium Volume (10-20 mL)
• Large Volume (>20 mL)
• Others

Global Implantable Insulin Pump Market Size by Delivery Mode & CAGR (2026-2033)

• Market Overview
• Continuous Basal Delivery
• Bolus Delivery
• Combined Basal-Bolus Delivery
• Others

Global Implantable Insulin Pump Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Diabetes Clinics
• Homecare Settings
• Others

Global Implantable Insulin Pump Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• Pediatric (<=17 years)
• Adults (18-64 years)
• Geriatric (>=65 years)

Global Implantable Insulin Pump Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Type 1 Diabetes Mellitus (T1DM)
• Type 2 Diabetes Mellitus (T2DM)
• Others

Global Implantable Insulin Pump Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Pediatric (<=17 years)
• Adults (18-64 years)
• Geriatric (>=65 years)

Global Implantable Insulin Pump Market Size & CAGR (2026-2033)

• North America (Pump Type, Reservoir Size, Delivery Mode, End User, Age Group, Indication, Distribution Channel)
  • US
  • Canada
• Europe (Pump Type, Reservoir Size, Delivery Mode, End User, Age Group, Indication, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Pump Type, Reservoir Size, Delivery Mode, End User, Age Group, Indication, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Pump Type, Reservoir Size, Delivery Mode, End User, Age Group, Indication, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Pump Type, Reservoir Size, Delivery Mode, End User, Age Group, Indication, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic Plc. (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SOOIL Development Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bigfoot Biomedical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beta Bionics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diabeloop SACA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Debiotech S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi Apex Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ViCentra B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CeQur (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtrum Technologies Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Diagnostics S.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations